Vanderbilt Ingram Cancer Center

The Robert J. Kleberg Jr. and Helen C. Kleberg Foundation has awarded a $3 million grant to Vanderbilt-Ingram Cancer Center (VICC) investigators in support of VICC’s drug discovery program. The gift awarded over the next three years from the private, San Antonio, Texas-based foundation will enable VICC researchers to pursue the development of new compounds to block the activity of cancer-causing genes and proteins that had previously been considered “undruggable.” Read More

Pierre Massion, M.D., Cornelius Vanderbilt Professor of Medicine, has been named to direct the Vanderbilt-Ingram Cancer Center (VICC) Cancer Early Detection and Prevention Initiative. Read More

For some people, cancer—especially colon cancer—is a persistent and potentially deadly visitor affecting family members from one generation to the next. Vanderbilt-Ingram Cancer Center, in partnership with the Colon Cancer Alliance, is hosting a free seminar to educate the public about risk factors associated with the disease. Read More

For some people cancer, especially colon cancer, is a persistent and potentially deadly visitor affecting family members from one generation to the next. Individuals who have a parent, sibling or child diagnosed with colon cancer have double the risk of developing the disease. Read More

Cancer patients who live near Spring Hill, Tennessee, can now receive care from an experienced medical oncologist at Vanderbilt-Ingram Cancer Center (VICC) at Spring Hill instead of traveling to the main campus in Nashville. Read More

Kamran Idrees, M.D., MSCI, assistant professor of Surgery, has received a Young Investigator Award from the Society of Surgical Oncology Foundation (SSO). Read More

A cancer research consortium headed by investigators at Vanderbilt-Ingram Cancer Center and two other institutions have received $12 million in federal funding to help determine why African-American women die at a higher rate and have more aggressive breast cancer than white women. Read More

The Centers for Medicare & Medicaid Services (CMS) today announced that it has selected Vanderbilt University Medical Center to participate in a care delivery model that supports and encourages higher quality, more coordinated cancer care. The Medicare arm of the Oncology Care Model includes more than 3,200 oncologists — about one-fifth of U.S. oncology specialists — and will involve approximately 155,000 Medicare beneficiaries nationwide. Read More

Imaging with a compound that binds to neuroendocrine cells is a safer and more effective way to detect rare neuroendocrine tumors. Read More

Christine Lovly, M.D., Ph.D., assistant professor of Medicine and Cancer Biology, has been selected to testify before members of Congress about the importance of cancer research, including early training programs for individuals interested in science. Read More

President Barack Obama has nominated Scott Hiebert, Ph.D., professor of Biochemistry and associate professor of Medicine, to serve as a member of the National Cancer Advisory Board (NCAB). Read More

Mia Levy, M.D., Ph.D., Ingram Assistant Professor of Cancer Research and director of Cancer Health Informatics and Strategy at Vanderbilt-Ingram Cancer Center (VICC), has been named a Komen Scholar by the Susan G. Komen organization. Read More

The ability to test patients’ cancers for individual differences, mainly at the genetic level, and to make treatment decisions based on those differences is the hallmark of precision medicine, and Vanderbilt University Medical Center (VUMC) is among the leaders of this new approach to diagnosis and treatment. Read More

The "People's Guide to Nashville," an album of children's music with prosocial messaging, and the inaugural Accessibility Map-a-Thon at Vanderbilt are among projects created and implemented by the 2015-16 Curb Center Public Scholars. Read More

A top Vanderbilt-Ingram Cancer Center (VICC) investigator recently met with Vice President Joe Biden regarding the National Cancer Moonshot Initiative, a major national program to identify, fund and accelerate the most promising research leading to cancer cures. Read More

Two Vanderbilt students were recognized for their contributions to cancer research during the Vanderbilt-Ingram Cancer Center (VICC) Annual Scientific Retreat held May 6 at the Vanderbilt University Student Life Center. Read More

Craig Thompson, M.D., president and CEO of Memorial Sloan Kettering Cancer Center, spoke about his lab’s research linking metabolism to stem cell maintenance during his recent Flexner Discovery Lecture. Read More

Rob Schieber and Jordan Lawhead each moved to Nashville to pursue a career in music. Songwriter and publisher Kris Bergsnes introduced them knowing they were both cancer survivors. Read More

When former Nashvillian Carol O’Hare speaks about a specific group of physicians at Vanderbilt-Ingram Cancer Center (VICC), her voice softens, and she refers to them affectionately as “my fellows.” Read More

Craig Thompson, M.D., president and CEO of Memorial Sloan Kettering Cancer Center, will deliver the next Flexner Discovery Lecture on May 5. Read More